Congo Faces Unprecedented Ebola Outbreak without Approved Vaccine Protection
WHO allocated 20,000 doses for the research vaccination program as officials seek evidence on Ervebo’s protection against Ebola Bundibugyo virus.
9 Articles
9 Articles
Congo faces unprecedented Ebola outbreak without approved vaccine protection
As the Ebola outbreak spreads unabated in the Democratic Republic of the Congo (DRC), vaccine developers are scrambling to develop and test a vaccine candidate that will target the species at its center.
The enormous Central African country is going through the most deadly Ebola epidemic in its history. Declared in May, it has already caused 3,639 deaths and infected 7,541 people, according to the latest report of the National Institute of Public Health released on Saturday. The epidemic is caused by the Bundibugyo strain of the virus, for which there is no specific immunizer or treatment so far, although there are two vaccines in clinical trial…
Médecins Sans Frontières launches trial of the vaccine against Ebola in DR Congo
The international organisation Médecins Sans Frontières (MSF) has launched a trial in the Democratic Republic of the Congo (DRC) to assess the effectiveness of the Ervebo vaccine against Ebola caused by the Bundibugyo virus. The organisation...
DRC: MSF conducts an vaccination study among frontline workers against Ebola disease
As the Ebola disease outbreak, caused by the Bundibugyo virus, continues to spread in the Democratic Republic of Congo (DRC), Médecins Sans Frontières/Doctors Without Borders (MSF) and Epicentre, its epidemiological research centre, are launching BRAVO- an important study that will follow frontline workers over time to assess the effect of the ERVEBO vaccine. The study [...]
Ebola Vaccine trial is underway in DR Congo - The Canadian Media
IBNS-CMEDIA: An Ebola vaccine trial is underway in the Democratic Republic of the Congo (DRC), involving frontline health workers and others involved in the response. The UN World Health Organization (WHO) said on Monday that 20,000 doses of the Ervebo vaccine have been allocated for the research vaccination programme in Ituri province. The aim of
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
